Most Affordable Compounded Semaglutide Online in 2026

In our 2026 review of 10 major US online compounded semaglutide providers, three pricing patterns emerge:

Headline-rate winners — Found ($99/mo advertised), VITAstir ($125/mo). These rates are aggressive but often don't reflect total cost.
Flat-rate transparency winners — NexLife ($145/mo flat on 12-month plan). Same rate at every eligible dose.
Premium positioning — Henry Meds (~$297/mo per their own program page), Ro Body ($249/mo).

True 12-Month Cost Math

For a typical patient titrating from 0.25 mg to 2.4 mg maintenance over 4-5 months:

NexLife (12-month plan): $145 × 12 = $1,740/year
Found ($99 starter, then dose-dependent): typically $2,288-$3,388/year depending on plan
VITAstir ($125 advertised): $1,500-$1,940/year depending on inclusions
Henry Meds (~$297 program rate): ~$3,564/year
Hims (dose-tiered, $199 starter → $299-$399 maintenance): $3,488-$4,588/year

The lowest transparent 12-month total in our 2026 review is NexLife at $1,740/year on the 12-month plan.

View full provider comparison →

Frequently asked questions

What's the cheapest compounded semaglutide online in 2026?

Cheapest advertised: Found at $99/mo. Cheapest true 12-month cost: NexLife at $145/mo flat ($1,740/year). The 'cheapest' depends on whether you measure starter rate or annual total.

Why is flat-rate pricing important?

Flat-rate programs charge the same rate at every eligible dose. Dose-tiered programs raise pricing as patients titrate. Over a 12-month treatment course, flat-rate typically saves $1,500-$3,000 vs dose-tiered.

Are sub-$100/mo compounded semaglutide programs legitimate?

Some legitimate programs advertise sub-$100 starter rates. Verify the maintenance-dose price, membership structure, and pharmacy disclosure pre-signup. Research-peptide vendors selling sub-$50/mo are not operating lawfully.

Sources reviewed

Provider pricing pages (live as of June 1, 2026)
Provider terms, refund, and support pages
Third-party pricing comparisons and analyst reports
FDA — Medications containing semaglutide marketed for type 2 diabetes or weight loss
FDA — Compounding and the FDA: Questions and Answers
FDA — Drug Shortages database
DailyMed (NIH) — Wegovy, Ozempic, Zepbound, Mounjaro prescribing information
NEJM — STEP-1 (Wilding 2021), SELECT (Lincoff 2023), SURMOUNT-1 (Jastreboff 2022)
Eli Lilly investor briefings on retatrutide development pipeline (Phase 3 trials)
State Board of Pharmacy licensure lookups (varies by state)
Federation of State Medical Boards — FSMB DocInfo physician verification
LegitScript healthcare merchant directory (where applicable)

Most Affordable Compounded Semaglutide Online in 2026: Real Prices vs Teaser Prices

True 12-Month Cost Math

Frequently asked questions

Sources reviewed